Gland Pharma adds Kotak Mutual Fund meeting to September investor schedule
- Gland Pharma added a one-on-one meeting with Kotak Mutual Fund on September 9, 2026
- The update brings the total scheduled engagements for September 2026 to eight distinct events
- Previous meetings with Carnelian Capital, First Ray Capital, and others remain unchanged
- Disclosures were made pursuant to SEBI LODR Regulation 30 on September 4, 2026
*this image is generated using AI for illustrative purposes only.
Gland Pharma has updated its schedule of analyst and institutional investor meetings for September 2026. The company added a one-on-one session with Kotak Mutual Fund on September 9, 2026, to its existing engagement calendar.
The disclosure was issued on September 4, 2026, pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This filing ensures transparency regarding the firm's interactions with market participants during the specified period.
Updated Meeting Schedule
The revised calendar now includes the additional engagement with Kotak Mutual Fund alongside previously announced meetings with Carnelian Capital, First Ray Capital, WCM Investment, LIC MF, ICICI Securities, and JP Morgan. The company will also participate in the BofA Securities 2026 Asia Pacific Conference from September 21 to September 22.
| Date | Investor/Analyst/Fund Name | Type of Meeting |
|---|---|---|
| September 03, 2026 | Carnelian Capital | One-on-One Meeting |
| September 04, 2026 | First Ray Capital | One-on-One Meeting |
| September 04, 2026 | WCM Investment arranged by Jefferies | One-on-One Meeting |
| September 07, 2026 | LIC MF arranged by 360One | One-on-One Meeting |
| September 09, 2026 | Kotak Mutual Fund | One-on-One Meeting |
| September 18, 2026 | Group meeting arranged by ICICI Securities | Group Meeting |
| September 21-22, 2026 | BofA Securities 2026 Asia Pacific Conference | One-on-One & Group Meetings |
| September 24, 2026 | Group meeting arranged by JP Morgan | Group Meeting |
Regulatory Disclosure
The company noted that the schedule is subject to change due to exigencies on the part of the investors, analysts, or the company itself. Sampath Kumar Pallerlamudi, Company Secretary and Compliance Officer, signed the disclosure.
Historical Stock Returns for Gland Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.84% | +2.05% | +13.69% | +63.38% | +56.24% | -26.49% |
How might the addition of Kotak Mutual Fund to the engagement calendar signal shifts in domestic institutional sentiment towards Gland Pharma's growth trajectory?
What specific strategic updates or financial guidance is Gland Pharma likely to present at the BofA Securities 2026 Asia Pacific Conference to attract international capital?
Could the high frequency of meetings with major players like JP Morgan and ICICI Securities indicate upcoming material announcements, such as earnings revisions or new product launches?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
